Design Therapeutics (DSGN)'s 30-day implied volatility (IV30) was 63.0% at the close on November 11, 2026, down from 66.0% the day before, against a 52-week range of 46.0% to 109.6%. Its 20-day historical volatility was 67.9%.
Data as of November 11, 2026.